Literature DB >> 30505501

Interstitial lung disease associated with anti-citrullinated peptide/protein antibody-positive anti-synthetase syndrome.

Hideaki Yamakawa1,2, Eri Hagiwara1, Tae Iwasawa3, Ryota Otoshi1, Erina Tabata1, Satoshi Ikeda1, Ryo Okuda1, Tomohisa Baba1, Shinichiro Iso4, Koji Okudela5, Tamiko Takemura6, Shinji Sato7, Takashi Ogura1.   

Abstract

Little has been reported on the characteristics of interstitial lung disease (ILD) associated with anti-citrullinated peptide/protein antibody (ACPA)-positive anti-synthetase syndrome (ASS). We sought to investigate the clinical, radiologic, and pathologic features of patients with ILD associated with ACPA-positive ASS. Medical records of seven ILD patients with positive results of both ACPA and anti-aminoacyl-tRNA synthetase antibody were retrospectively reviewed. Five patients had clinical symptoms associated with ASS other than ILD. On high-resolution computed tomography (HRCT) analysis, a nonspecific interstitial pneumonia (NSIP) pattern was shown in 3 patients and NSIP with organizing pneumonia (OP) overlap in 2 patients. Coronal slices of these 5 patients showed lower lung disease predominance with traction caudally on major fissures due to lower lobe volume loss. These were features that could commonly be observed in ASS-associated ILD. Pathological findings available for 3 patients showed NSIP. The characteristics of ILD associated with ACPA-positive ASS appear to be similar to those of ILD associated with ASS, but not to rheumatoid arthritis (RA) or ACPA, especially in terms of the radiological findings.

Entities:  

Keywords:  Anti-synthetase syndrome (ASS); anti-citrullinated peptide/protein antibody (ACPA); interstitial lung disease (ILD); radiology

Year:  2018        PMID: 30505501      PMCID: PMC6236144          DOI: 10.21037/jtd.2018.09.42

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias.

Authors:  Kizuku Watanabe; Tomohiro Handa; Kiminobu Tanizawa; Yuji Hosono; Yoshio Taguchi; Satoshi Noma; Yoichiro Kobashi; Takeshi Kubo; Kensaku Aihara; Kazuo Chin; Sonoko Nagai; Tsuneyo Mimori; Michiaki Mishima
Journal:  Respir Med       Date:  2011-04-22       Impact factor: 3.415

2.  Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome.

Authors:  I Marie; S Dominique; A Janvresse; H Levesque; J-F Menard
Journal:  Respir Med       Date:  2012-01-24       Impact factor: 3.415

3.  Fleischner Society: glossary of terms for thoracic imaging.

Authors:  David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal:  Radiology       Date:  2008-01-14       Impact factor: 11.105

4.  Case of interstitial lung disease with anti-EJ and anti-CCP antibodies preceding rheumatoid arthritis.

Authors:  Hiromi Tomioka; Masahiro Kaneko; Yoshinori Kogata; Eiji Katsuyama; Seiko Ishikawa; Takao Fujii
Journal:  Respir Investig       Date:  2012-05-17

Review 5.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

6.  Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.

Authors:  Ana C Zamora; Sumedh S Hoskote; Beatriz Abascal-Bolado; Darin White; Christian W Cox; Jay H Ryu; Teng Moua
Journal:  Respir Med       Date:  2016-07-16       Impact factor: 3.415

7.  Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.

Authors:  Rohit Aggarwal; Elaine Cassidy; Noreen Fertig; Diane Carol Koontz; Mary Lucas; Dana P Ascherman; Chester V Oddis
Journal:  Ann Rheum Dis       Date:  2013-02-19       Impact factor: 19.103

Review 8.  Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.

Authors:  William D Travis; Gary Hunninghake; Talmadge E King; David A Lynch; Thomas V Colby; Jeffrey R Galvin; Kevin K Brown; Man Pyo Chung; Jean-François Cordier; Roland M du Bois; Kevin R Flaherty; Teri J Franks; David M Hansell; Thomas E Hartman; Ella A Kazerooni; Dong Soon Kim; Masanori Kitaichi; Takashi Koyama; Fernando J Martinez; Sonoko Nagai; David E Midthun; Nestor L Müller; Andrew G Nicholson; Ganesh Raghu; Moisés Selman; Athol Wells
Journal:  Am J Respir Crit Care Med       Date:  2008-04-03       Impact factor: 21.405

9.  Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetases.

Authors:  Yuko Waseda; Takeshi Johkoh; Ryoko Egashira; Hiromitsu Sumikawa; Keigo Saeki; Satoshi Watanabe; Ryo Matsunuma; Hazuki Takato; Yukari Ichikawa; Yasuhito Hamaguchi; Akira Shiraki; Yoshinao Muro; Masahide Yasui; Helmut Prosch; Christian Herold; Kazuo Kasahara
Journal:  Eur J Radiol       Date:  2016-05-24       Impact factor: 3.528

10.  Pulmonary manifestations of anti-ARS antibody positive interstitial pneumonia--with or without PM/DM.

Authors:  Hazuki Takato; Yuko Waseda; Satoshi Watanabe; Kanako Inuzuka; Nobuyuki Katayama; Yukari Ichikawa; Masahide Yasui; Masaki Fujimura
Journal:  Respir Med       Date:  2012-11-06       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.